This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Progeria children show potential life extension from lonafarnib study
In a Boston Children’s Hospital trial 27 treated children with progeria lived longer than 27 untreated peers, with 13 treated participants still alive after two years. researchers caution the lack of a placebo control and note unclear whether lonafarnib alone or with other drugs drove the benefit. The study, led by Dr. Leslie Gordon, suggests possible hope for Hutchinson Gilford progeria though not definitive proof.
MENTIONED IN THIS ARTICLE
Chicago
Francis Collins
National Institutes of Health
Collins
Hutchinson-Gilford
Leslie Gordon
Brown University
Journal of the American Medical Association
Boston Children’s Hospital
Howard Worman
Columbia University